Products

A RT-qPCR based method for the determination of Programmed death-ligand 1 (PD-L1) mRNA expression. The kit can be applied on RNA samples extracted from Circulating Tumor Cells (CTCs) of NSCLC, HNSCC and melanoma cancer patients.

A real-time qualitative PCR test that is based on the combination of allele-specific priming, asymmetric PCR, and melting curve analysis for the detection of PIK3CA mutations (E542K, E545K, E545Q, H1047R). The kit can be used on DNA samples extracted from FFPE tumor tissues, circulating tumor cells (CTCs) and plasma of breast cancer patients.